Wednesday, March 06, 2013

Medical Technology Investor Alert: Medical Alarm Concepts Holding, Inc. (MDHI) Receives Strategic Investment to Continue Strong Growth - Moves into Positive Operating Cash Flow for March 2013 Quarter

KING OF PRUSSIA, Pa. - March 6, 2013 (Investorideas.com Newswire) Medical Alarm Concepts Holding, Inc. (OTCQB:MDHI), today announced it has received an investment led by strategic partner, JTT-EMS LTD of Shijiazhuang, China. Under the terms of the investment, JTT-EMS purchased restricted common stock, which it plans to hold as a long-term investment. The financing, including additional investments by current shareholders, will total approximately $330,000.
"This is exciting financing for our Company that will allow us to maintain our strong growth," commented Ronnie Adams, CEO. "This strategic investment is straight common equity in the Company, which must be held for an extended period of time. There are no warrants, options, or any other enhancements. Over the past two quarters our business has turned the corner with strong growth, allowing us to reach positive cash flow. Because this growth is based on high quality recurring monthly revenues, we believe the positive operating cash flow we will report beginning in the March 2013 quarter will be sustainable moving forward."
The demand for the MediPendant® continues to grow at a rapid pace as a result of strong sales from the Company's retail partnership and growing online orders. Medical Alarm Concepts recently announced the signing of a major diversified national healthcare insurer that will offer the Company's MediPendant® product and monthly monitoring services to subscribers of selected healthcare programs. Additionally, the product will be included in the insurance carrier's dual demonstration program (Medicaid and Medicare) related contracts on which it may bid.


Use of funds from this new strategic investment will be primarily for inventory acquisition to meet growing demand. Secondary uses of funds will include completing the process of restoring the Company to fully reporting status, additional marketing programs, further reductions in trade payables, and general working capital.
The MediPendant® is a second-generation personal medical alarm and the only product in its category that allows for monitored, two-way communications and associated voice prompts directly through the pendant. Older generations of technology require the user to be in close proximity to the base station in order to speak and listen to the operator. With the MediPendant®, the customer can be anywhere within 600+ feet of their home, and in the event of an emergency, speak and listen to the EMT trained operator directly through the pendant.
Additional information on the MediPendant® can be viewed at www.MediPendant.com.
About MDHI
Medical Alarm Concepts Holdings, Inc. (MAC) develops and manufactures innovative products and practical solutions within the framework of a vast growing marketplace. MediPendant's® patented two-way voice technology enables the user to speak and listen directly through the pendant no matter where the user may be in and around their home. MediPendant® service also includes advanced features such as three-way calling that enables the operator to link loved ones directly into the emergency call in real time. Text message alerts are also standard, and are used to inform loved ones that the user has contacted an operator or has requested assistance. A standard PERS system does not enable the user to speak and listen through the pendant, thus limiting them to a small area in their home. There is always the risk that the user will not be heard by the call center operator if they are not within a short range of the base station.
Safe Harbor Statement
Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Company's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's filings with Securities and Exchange Commission.
Contact:
Medical Alarm Concepts Holding, Inc.
877-639-2929 Ext. 113
Paid News published at Investorideas.com Newswire:
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure :MDHI: March 2013 news and content distribution Investorideas.com newswire and syndication partners : $five thousand
More: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Tuesday, March 05, 2013

Biotech Stock Alert; 8K Filing; Medical Alarm Concepts Holding, Inc. (OTC: MDHI) to become a provider of personal medical alarms for Coventry Health Care, Inc. (NYSE: CVH)

Point Roberts, WA - March 5, 2013 (Investorideas.com Newswire) Investorideas.com, a leader in sector research for investors, issues an 8K filing alert for medical device company, Medical Alarm Concepts Holding, Inc. (OTCQB: MDHI.PK).



According to the filing: "On February 25, 2013, the Company signed a supply and services contract with Coventry Health Care, Inc., (NYSE: CVH) a diversified national insurer in the United States located in Bethesda, Maryland, which operates health plans, insurance companies, network rental and workers' compensation services companies.
Medical Alarm Concepts Holding, Inc. will become a provider of personal medical alarms for Coventry.
Under the terms of the agreement, Coventry Health Care, Inc. will offer the Company's MediPendant® product and monthly monitoring services to subscribers of selected healthcare programs provided by Coventry. Additionally, the Company's MediPendant® product has been, or may be, included in their dual demonstration programs (Medicare and Medicaid) related contracts on which Coventry Health Care, Inc. may bid.
The Company is expecting this contract to generate growth in revenue and earnings. As a result of gaining the contract, the Company plans to expand its business operations in the areas of manufacturing, financial management, research & development, and logistics."
http://www.sec.gov/Archives/edgar/data/1443089/000147124213000073/mdhifeb262013.htm
Full news: http://www.investorideas.com/news/2013/biotech/03041.asp
Additional information on the MediPendant can be viewed at www.MediPendant.com .
About MDHI (OTCQB: MDHI.PK),
Medical Alarm Concepts Holdings, Inc. (MAC) develops and manufactures innovative products and practical solutions within the framework of a vast growing marketplace. MediPendant's™ patented two-way voice technology enables the user to speak and listen directly through the pendant no matter where the user may be in and around their home. MediPendant™ service also includes advanced features such as three-way calling that enables the operator to link loved ones directly into the emergency call in real time.  Text message alerts are also standard, and are used to inform loved ones that the user has contacted an operator or has requested assistance. A standard PERS system does not enable the user to speak and listen through the pendant, thus limiting them to a small area in their home. There is always the risk that the user will not be heard by the call center operator if they are not within a short range of the base station.
Medical Alarm Concepts Holding, Inc.
Contact:
Medical Alarm Concepts Holding, Inc.
877-639-2929 Ext. 113
Paid News published at Investorideas.com Newswire:
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure :MDHI: March 2013 news and content distribution Investorideas.com newswire and syndication partners : $five thousand
More: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com 800 665 0411

China Logistics (OTCQB: CHLO) Positioning to Capitalize on Export Growth

Point Roberts, WA - March 5, 2013 (Investorideas.com newswire) - Investorideas.com, an investor research portal specializing in sector research for independent investors Issues an alert for China Logistics Group, Inc. ( OTCQB: CHLO), an international freight forwarder and logistics management company, following recent import and export data from China.


Shanghaidaily.com just reported:
"Commerce minister cautiously optimistic exports will improve
CHINA is cautiously optimistic about exports this year, Commerce Minister Chen Deming said today.
"If the external environment does not change drastically, China's exports may fare better than last year," Chen said during the sidelines of the annual session of the Chinese People's Political Consultative Conference in Beijing.
China , the world's largest exporter, sold goods worth US$2.05 trillion in 2012 to overseas markets, up 7.9 percent from a year earlier.
The recovery from last year's eurozone debt crisis seemed to be accelerating as China's exports jumped 25 percent in January from the year before, far exceeding expectations.
Lu Zhengwei, chief economist at Industrial Bank, said exports may stabilize in February with overseas sales expanding 15 percent on an annual basis."
China Logistics Group, Inc. ( OTCQB: CHLO) recently reported that it has begun to explore plans to establish its own warehouse facility for international and domestic storage and logistics. The company believes this strategy would serve to compliment its current international freight forwarding, logistics management, and trucking services.
The Company also recently reported that it sees shipping volumes doubling in 2013 for its South American route out of Shanghai launched in 2012.
In the first 9 months of 2012 ending September 30 th, 2012, the total freight volume arranged by China Logistics from its Shanghai location to Europe, United States, Middle East and Southeast Asia was approximately 3,000 TEU or, twenty foot equivalent units, generating revenues of approximately $6,700,000 and gross profits of $1,200,000. Management sees a growth of 20% to 30% for the company through these four major international routes in 2013 which is expected to significantly improve overall financial performance over the course of this year.
Article source: http://www.shanghaidaily.com/article/?id=525150&type=Business
About China Logistics Group, Inc.
China Logistics Group, Inc. (OTCQB: CHLO) is a U.S. company doing business in China through its subsidiary Shandong Jiajia International Freight & Forwarding Co., Ltd. (Shandong Jiajia). Established in 1999; Shandong Jiajia is an international freight forwarder and logistics manager located in China. Shandong Jiajia acts as an agent for international freight and shipping companies. It sells cargo space and arranges land, maritime, and air international transportation for clients seeking primarily to export goods from China. For more information please visit http://www.chinalogisticsinc.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Investorideas.com Disclaimer
Published at Investorideas.com newswire
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. CHLO- one month news publication and email distribution starting February 13, 2013. Disclosure: compensation: three thousand per week http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Freight and Logistics Stocks to Watch: AIRT, CHLO, FWRD, RLGT

Point Roberts, WA - March 5, 2013 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors Issues a snapshot for freight and logistics stocks. Companies in this sector are showing impressive revenue growth in contrast to shipping stocks which have been struggling.


 
 
In a recent article in The Loadstar, a logistics and supply chain management publication, it was noted, "Results show that it's better to be in logistics than in liner shipping."
On February 27 th, Damco, one of the world's leading freight forwarding and logistics service providers reported a 19% increase in net revenue compared to 2011. Net revenue in 2012 increased to 3,272 million USD, from 2,752 in 2011. Gross profit saw a rise of 7% to 807 million USD in 2012.
On February 1 st Air T Inc. (Nasdaq: AIRT) reported consolidated revenues for fiscal 2013's third quarter were $26,703,000, an increase of 4% compared to the similar 2012 fiscal quarter. Consolidated revenues for the first nine months of the 2013 fiscal year were $72,353,000 or 7% higher than the prior year comparable period.
On February 4 th China Logistics ( OTCQB: CHLO) an international freight forwarder and logistics management company, reported that management sees strong growth in volumes for its four largest international routes to Europe, United States, Middle East and Southeast Asia.
In the first 9 months of 2012 ending September 30 th, 2012, the total freight volume arranged by China Logistics from its Shanghai location to Europe, United States, Middle East and Southeast Asia was approximately 3,000 TEU or, twenty foot equivalent units, generating revenues of approximately $6,700,000 and gross profits of $1,200,000. Management sees a growth of 20% to 30% for the company through these four major international routes in 2013 which is expected to significantly improve overall financial performance over the course of this year.
Forward Air Corporation (NASDAQ:FWRD) also reported results for the fourth quarter and year ended December 31 st, 2012 on February 11 th.Operating revenue for the quarter ended December 31 st, 2012 increased 4.9% to $155.5 million from $148.2 million for the same quarter in 2011. Income from operations was $24.0 million, compared with $23.6 million for the fourth quarter of 2011, an increase of 1.7%. Net income per diluted share for the fourth quarter of 2012 was $0.54 compared with $0.50 in the same quarter of 2011, an increase of 8.0%.
Operating revenue for the year ended December 31 st, 2012 increased 8.9% to $584.4 million from $536.4 million for the year ended December 31 st, 2011.
Radiant Logistics, Inc. (NYSE MKT: RLGT) , a domestic and international logistics services company, reported financial results on February 11 th for the three and six months ended December 31 st, 2012.•Total revenues increased 7.7% to $78.2 million in the second fiscal quarter of 2013 from $72.6 million for the comparable prior year period.
Article reference: http://theloadstar.co.uk/results-show-that-its-better-to-be-in-logistics-than-in-liner-shipping/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Investorideas.com Disclaimer
Published at Investorideas.com newswire
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. CHLO- one month news publication and email distribution starting February 13, 2013. Disclosure: compensation: three thousand per week http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Monday, March 04, 2013

Medical Alarm Concepts (MDHI) Trades Up on News Gaining over 23%

Point Roberts, WA - March 4, 2013 (Investorideas.com Newswire) Investorideas.com, a leader in sector research for investors, issues a trading alert for medical device company, Medical Alarm Concepts Holding, Inc. (OTCQB: MDHI.PK). The stock is trading up over 23% on over 9 Million shares following news.


The Company released an update today with details about its recently accelerating growth rate and a contract signed with a diversified national insurer where Medical Alarm Concepts will become a provider of personal medical alarms.
Investorideas.com Newswire According to the release, "Under the terms of the new agreement, the diversified national insurer will offer the Company's MediPendant® product and monthly monitoring services to subscribers of selected healthcare programs. Additionally, the Company's MediPendant® product has been, or may be, included in their dual demonstration programs (Medicare and Medicaid) related contracts on which Coventry Health Care, Inc.( NYSE:CVH ) may bid. Additional information regarding this contract can be viewed on the website hosted by the US Securities & Exchange Commission at the following link:” http://www.sec.gov/Archives/edgar/data/1443089/000147124213000073/mdhifeb262013.htm
Full news: http://www.investorideas.com/news/2013/biotech/03041.asp
Additional information on the MediPendant can be viewed at www.MediPendant.com .
About MDHI ( OTCQB: MDHI.PK ),
Medical Alarm Concepts Holdings, Inc. (MAC) develops and manufactures innovative products and practical solutions within the framework of a vast growing marketplace. MediPendant's™ patented two-way voice technology enables the user to speak and listen directly through the pendant no matter where the user may be in and around their home. MediPendant™ service also includes advanced features such as three-way calling that enables the operator to link loved ones directly into the emergency call in real time.  Text message alerts are also standard, and are used to inform loved ones that the user has contacted an operator or has requested assistance. A standard PERS system does not enable the user to speak and listen through the pendant, thus limiting them to a small area in their home. There is always the risk that the user will not be heard by the call center operator if they are not within a short range of the base station.
Medical Alarm Concepts Holding, Inc.
Contact:
Medical Alarm Concepts Holding, Inc.
877-639-2929 Ext. 113
Paid News published at Investorideas.com Newswire:
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure :MDHI: March 2013 news and content distribution Investorideas.com newswire and syndication partners : $five thousand
More: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com 800 665 0411

Medical Technology Investor Alert: Medical Alarm Concepts (MDHI) Signs Deal with Health Care Insurance Provider for Medical Alarms

KING OF PRUSSIA, PA - March 4, 2013 (Investorideas.com Newswire) Medical Alarm Concepts Holding, Inc. ( OTCQB: MDHI.PK ), today provided details about its recently accelerating growth rate and a contract signed with a diversified national insurer where Medical Alarm Concepts will become a provider of personal medical alarms.

Under the terms of the new agreement, the diversified national insurer will offer the Company's MediPendant® product and monthly monitoring services to subscribers of selected healthcare programs. Additionally, the Company's MediPendant® product has been, or may be, included in their dual demonstration programs (Medicare and Medicaid) related contracts on which Coventry Health Care, Inc.( NYSE:CVH ) may bid. Additional information regarding this contract can be viewed on the website hosted by the US Securities & Exchange Commission at the following link:
http://www.sec.gov/Archives/edgar/data/1443089/000147124213000073/mdhifeb262013.htm
Mr. Ronnie Adams commented, "We are expecting this contract to generate growth in revenues and earnings. As a result of gaining this contract, we plan to expand our business operations in the areas of manufacturing, financial management, research and development, and logistics.”
Over the past few months Medical Alarm Concepts has been experiencing strong growth in revenues due to an expanding retail presence, strong Internet sales and new international opportunities. Having now reached operational cash flow profitability, the Company is expecting to report positive cash flow for the full quarter ending March 31, 2013 and throughout calendar 2013.
"We are very pleased that our cash flow will be based on very high quality recurring revenues. Our retail partnerships remain strong. This week we began the first of two promotions that are scheduled for the late winter and early spring period. Thus far, sales have been extremely robust, which is strongly adding to our recurring monthly revenue base. We are expecting calendar 2013 to be a year of very strong growth and cash flow.
The MediPendant is a second-generation personal medical alarm and the only product in its category that allows for monitored, two-way communications directly through the pendant along with patented voice prompts. Older generations of technology require the user to be in close proximity to the base station in order to speak and listen to the operator. With the MediPendant the customer can be anywhere within approximately 600 feet of their home and in the event of an emergency speak and listen to the EMT trained operator directly through the pendant.
Additional information on the MediPendant can be viewed at www.MediPendant.com .
About MDHI ( OTCQB: MDHI.PK ),
Medical Alarm Concepts Holdings, Inc. (MAC) develops and manufactures innovative products and practical solutions within the framework of a vast growing marketplace. MediPendant's™ patented two-way voice technology enables the user to speak and listen directly through the pendant no matter where the user may be in and around their home. MediPendant™ service also includes advanced features such as three-way calling that enables the operator to link loved ones directly into the emergency call in real time.  Text message alerts are also standard, and are used to inform loved ones that the user has contacted an operator or has requested assistance. A standard PERS system does not enable the user to speak and listen through the pendant, thus limiting them to a small area in their home. There is always the risk that the user will not be heard by the call center operator if they are not within a short range of the base station.
Safe Harbor Statement
Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Company's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's filings with Securities and Exchange Commission.
SOURCE: Medical Alarm Concepts Holding, Inc.
Contact:
Medical Alarm Concepts Holding, Inc.
877-639-2929 Ext. 113
Paid News published at Investorideas.com Newswire:
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure :MDHI: March 2013 news and content distribution Investorideas.com newswire and syndication partners : $five thousand
More: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Friday, March 01, 2013

China Stock Trading Alert; China Logistics (OTCQB: CHLO) Gains over 15%

Point Roberts, WA - March 1, 2013 (Investorideas.com newswire) - Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors Issues a trading alert for China Logistics Group, Inc. ( OTCQB: CHLO), an international freight forwarder and logistics management company. The stock is trading up 15.79% , trading at 0.0220, gaining 0.0030(15.79%) as of 12:40PM EST on over 400,000 shares.
Investorideas.com Newswire The Company reported earlier this week that it has begun to explore plans to establish its own warehouse facility for international and domestic storage and logistics. The company believes this strategy would serve to compliment its current international freight forwarding, logistics management, and trucking services.
The Company also recently reported that it sees shipping volumes doubling in 2013 for its South American route out of Shanghai launched in 2012.
About China Logistics Group, Inc.
China Logistics Group, Inc. (OTCQB: CHLO) is a U.S. company doing business in China through its subsidiary Shandong Jiajia International Freight & Forwarding Co., Ltd. (Shandong Jiajia). Established in 1999; Shandong Jiajia is an international freight forwarder and logistics manager located in China. Shandong Jiajia acts as an agent for international freight and shipping companies. It sells cargo space and arranges land, maritime, and air international transportation for clients seeking primarily to export goods from China. For more information please visit http://www.chinalogisticsinc.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Investorideas.com Disclaimer
Published at Investorideas.com newswire
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. CHLO- one month news publication and email distribution starting February 13, 2013. Disclosure: compensation: three thousand per week plus equivalent in shares       http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Thursday, February 28, 2013

China Shipping Stocks Alert; China Logistics (OTCQB: CHLO), China Shipping Container Lines (2866-HK), China Shipping Development (1138.HK)

Point Roberts, WA - February 28, 2013 (Investorideas.com newswire) - Investorideas.com, an investor research portal specializing in sector research for independent investors Issues a snapshot for China shipping stocks and a trading alert for China Logistics Group, Inc. ( OTCQB: CHLO), China Shipping Container Lines Co Ltd (CSCL) (2866-HK), (SHA:601866) and China Shipping Development Company Limited (1138.HK).

China Logistics ( OTCQB: CHLO) is trading up over 4%. The Company reported yesterday that it has begun to explore plans to establish its own warehouse facility for international and domestic storage and logistics. The company believes this strategy would serve to compliment its current international freight forwarding, logistics management, and trucking services.
The Company also recently reported that it sees shipping volumes doubling in 2013 for its South American route out of Shanghai launched in 2012.
Investorideas.com Newswire China Shipping Container Lines Co Ltd (CSCL) (2866-HK) last traded at $2.30, up 0.05(2.22%) on over 31 Million shares.
China Shipping Development Company Limited (1138.HK) traded at $4.32, gaining 0.16(3.85%) on over 10 Million shares.
Investorideas.com Newswire About China Logistics Group, Inc.
China Logistics Group, Inc. (OTCQB: CHLO) is a U.S. company doing business in China through its subsidiary Shandong Jiajia International Freight & Forwarding Co., Ltd. (Shandong Jiajia). Established in 1999; Shandong Jiajia is an international freight forwarder and logistics manager located in China. Shandong Jiajia acts as an agent for international freight and shipping companies. It sells cargo space and arranges land, maritime, and air international transportation for clients seeking primarily to export goods from China. For more information please visit http://www.chinalogisticsinc.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Investorideas.com Disclaimer
Published at Investorideas.com newswire
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. CHLO- one month news publication and email distribution starting February 13, 2013. Disclosure: compensation: three thousand per week plus equivalent in shares       http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Medical Technology Breaking News: Aethlon Medical (OTCBB:AEMD) Note: Multiple Shots on Goal - A Therapeutic Strategy to Address Infectious Disease & Cancer

SAN DIEGO - February 28, 2013 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.


I recently attended a healthcare related event that featured a panel discussion comprised of life science bankers and venture capitalists. While members of this panel often had differing viewpoints, they did mutually agree they were interested in emerging therapeutic candidates that provided more than one "shot on goal," meaning the possibility of a single therapy that could address more than one disease indication.
In the case of the Aethlon Hemopurifier®, we have created a therapeutic filtration device that selectively captures a broad-spectrum of disease promoting particles from circulation without eliminating blood components required for health. However, instead of immobilizing an antibody or agent that specifically binds to a single pathogen, we made the bold decision to deploy the capabilities of a lectin affinity agent that binds to a unique structure evolved and shared by viruses and cancer as a survival mechanism that allows disease progression to continue below the surveillance of the immune system. In the treatment of Hepatitis C virus (HCV), we have demonstrated that our Hemopurifier® can eliminate the presence of HCV in as little a seven days when utilized in combination with interferon-based therapy. Short-term administration of the same device has reduced viral load by greater than 90% in an HIV-AIDS dialysis patient who was not receiving any form of antiviral drug therapy. Additionally, government and non-government research organizations have demonstrated the Hemopurifier® captures a wide range of bioterror and pandemic threats. In regards to cancer, the same Hemopurifier® deployed in infectious disease studies has emerged to be the first therapeutic strategy to address tumor-secreted exosomes. Tumor-secreted exosomes are a vital therapeutic target as they have recently been discovered to be immunosuppressive and play significant role in seeding the creation and spread of cancer metastasis.
So, how is it possible that one therapy can address a breadth of disease conditions? Dr. Annette Marleau, our Director of Tumor Immunology provides the following summary review for interested parties, including medical and non-medical industry shareholders of Aethlon Medical:
Intriguingly, there are converging biological mechanisms underlying viral infections and cancer, despite the fact that these are distinct categories of disease that are typically addressed with different therapies. Common disease processes in infections and cancer include the modalities by which disease is spread and the involvement of the immune system. The latter point stems from the fact that both tumor cells and infectious pathogens are viewed as "foreign invaders" by the immune system. In response, diseased cells have evolved tactics for manipulating the immune system to their advantage in order to propagate disease. One of the key pathogenic maneuvers employed by viruses and tumors is the systemic distribution of disease-mediating particles that spread molecular information from diseased cells to healthy cells.
Of relevance to our Hemopurifier® is the observation that critical disease-mediating particles in many viral infections and cancer display high-mannose glycoproteins on their surfaces. These surface features arise during the process of glycosylation, whereby carbohydrate residues such as mannose are tagged onto proteins to ensure proper protein assembly and function in healthy cells. Not surprisingly, this process becomes perturbed in several disease conditions, thereby changing the biologic functions of proteins. To define the glycoprotein signatures associated with specific disease conditions, researchers have applied panels of carbohydrate-binding proteins (lectins) to determine the relative compositions of specific carbohydrate residues in cellular material. Extrapolating on the use lectins as research reagents for biomarker discovery, our device platform leverages the specificity of lectins for glycoprotein-coated particles for therapeutic affinity capture.
Among the spectrum of targets of the Hemopurifier® are enveloped viruses, a broad group of infectious pathogens that are enriched for high-mannose glycoproteins on their outer surfaces. The envelope glycoproteins have well-recognized roles in viral attachment and integration into host cells (1). Scientific studies have demonstrated that lectins have potent anti-viral activity by virtue of their interference with the functions of envelope glycoproteins. Indeed, the current version of the Hemopurifier® has been demonstrated to capture a spectrum of enveloped viruses including HIV, Dengue virus, orthopoxviruses (vaccinia and monkeypox), influenza viruses (H5N1 bird flu, 1918 Spanish flu), and Ebola.
In addition to addressing viral infections, the Hemopurifier also captures cancer-derived exosomes that also display high-mannose glycoproteins on their outer surfaces (2). Exosomes are membranous nanovesicles secreted by diverse tumor types that act as inter-cellular messengers to spread oncogenic signals. Evidence is emerging that cancer exosomes are involved in practically every aspect of malignancy, including apoptosis of immune cells, tissue invasion, angiogenesis, metastases and resistance to therapeutic drugs. The genomic and proteomic content of exosomes, as well as the exosome load in the circulation, are known to correlate with tumor stage and metastasis, suggesting that exosomes can serve as disease biomarkers (3,4). Accordingly, exosomes have emerged as critical targets in cancer care, and there is currently an unmet need for means of targeting these nanovesicles therapeutically.
Based on their common glycoprotein signatures, the biogenesis of virions and exosomes has been suggested to share a conserved evolutionary pathway (5). These nano-sized particles (both in the 50-300 nm range) use their heavily glycosylated surfaces for entry into target cells, where virions and exosomes transfer pathogenic information in the form of proteins and/or genetic material. These particles also hijack the intracellular machinery to affect cell growth and survival pathways, while also promoting the formation of more disease-mediating particles. Indeed, newly generated virions and exosomes are both secreted by budding off from the plasma membrane of diseased cells, during which time it is believed they inherit glycoprotein-rich membrane components (6). Thus, the fields of viral and cancer immunology converge mechanistically at the level of the glycoprotein "fingerprints" on key disease-mediating particles.
The intersection of the pathways exploited by virions and exosomes is exemplified by the ability of certain viruses to package their infectious material into exosomes. For example, HIV-infected cells secrete exosomes containing Nef or "Negative Factor", an abundant HIV protein that induces death of CD4+ T cells, a hallmark of AIDS (7). Viruses and exosomes can therefore act as co-dependent entities for spreading infection and impeding host immunity. A validation study conducted by our collaborators at the Morehouse School of Medicine revealed that the Hemopurifier® captures NEF exosomes and therefore holds promise as an anti-viral strategy for co-targeting both Nef exosomes and HIV virions in circulation.
Collectively, these lines of evidence provide a compelling scientific rationale for why the Hemopurifier® is a candidate broad-spectrum countermeasure against both viral pathogens and cancer. In both of these clinical scenarios, we propose to advance the Hemopurifier as an adjunct to standard of care therapies for reducing the systemic burden of disease-mediating particles and unmasking the native immune response in patients.
(1) Balzarini J. Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat Rev Microbiol 2007;5:583.
(2) Batista BS et al. Identification of a conserved glycan signature for microvesicles. J Proteome Res 2011;10:4624.
(3) Taylor DD and Gercel-Taylor C. Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol 2011;33:441.
(4) Henderson MC and Azorsa DO. The genomic and proteomic content of cancer cell-derived exosomes. Front Oncol 2012;2:38.
(5) Krishnamoorthy L et al. HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin. Nat Chem Biol 2009;5:244.
(6) Wurdinger T et al. Extracellular vesicles and their convergence with viral pathways. Adv Virol 2012:767694.
(7) Lenassi M et al. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 2010;11:110.
About Aethlon Medical
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
About The Aethlon Hemopurifier®
The Aethlon Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of infectious viral pathogens and immunosuppressive proteins from the entire circulatory system. In the treatment of Hepatitis C virus (HCV), human studies have demonstrated that Hemopurifier® therapy may improve immediate, rapid and sustained virologic response rates when administered in the first few days of standard-of-care drug therapy. In addition to accelerating viral load depletion, post-treatment analysis of the Hemopurifier® has documented the capture of up to 300 billion HCV copies of HCV during a single six-hour treatment. Access to Hemopurifier® therapy is available on a compassionate-use basis through the Medanta Medicity Institute (Medicity), a leading center for medical tourism in India. The Medicity is offering treatment access to infected individuals who previously failed or subsequently relapsed standard-of-care drug regimens. The Hemopurifier® is also being offered as a salvage therapy to infected individuals who suffer a viral breakthrough during standard-of-care therapy. U.S. studies of the Hemopurifier® are currently pending approval of an IDE submitted to FDA.
The Aethlon Hemopurifier® and Cancer
In addition to the opportunity to address a broad-spectrum of infectious viral pathogens, the Hemopurifier® has been discovered to capture tumor-derived exosomes underlying several forms of cancer. Tumor-derived exosomes have recently emerged to be a vital therapeutic target in cancer care. These microvesicular particles suppress the immune response in cancer patients through apoptosis of immune cells and their quantity in circulation correlates directly with disease progression. Beyond possessing immunosuppressive properties, tumor-derived exosomes facilitate tumor growth, metastasis, and the development of drug resistance. By addressing this unmet medical need, the Hemopurifier® is positioned as an adjunct to improve established cancer treatment regimens.
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the company can successfully protect its intellectual property, that removal of exosomes from the human body will impact or lead to successful treatment of cancer, or that exosomes are the cause of tumor growth and progression, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Published at Investorideas.com Newswire
More info on AEMD at Investorideas.com Visit: http://www.investorideas.com/CO/AEMD/
Disclaimer: Investorideas.com is a third party publisher of news and research. Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. If you have any questions regarding information in this press release please contact the company listed in the press release. Aethlon Medical, Inc. is currently an annual news release client at Investorideas.com and compensates Investorideas.com $2425 quarterly to publish and distribute news with Investorideas and its syndication partners
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Wednesday, February 27, 2013

Shipping Stocks Breaking News: China Logistics (OTCQB: CHLO) Explores Plans For its Own Warehouse Facility for International and Domestic Storage and Logistics

SHANGHAI, CHINA - February 27, 2013 (Investorideas.com newswire) - China Logistics Group, Inc. (OTCQB: CHLO), an international freight forwarder and logistics management company, announced today that management has begun to explore plans to establish its own warehouse facility for international and domestic storage and logistics. The company believes this strategy would serve to compliment its current international freight forwarding, logistics management, and trucking services.

The Company is considering plans to purchase or lease land use rights to an 80,000 square meter parcel of land in Dafeng City in Jiangsu Province for the warehouse operation which would serve as a storage hub to service this growing port city. Dafeng port is the only deep-water port in the central Jiangsu coast making it an ideal location for this type of operation. Management is evaluating plans to build 40,000 square meters of warehouse space featuring high-bay storage, optional temperature-controlled space, sprinkler systems, drive-in doors, and specialty equipment. Management will explore a number of alternatives to finance the project should the company decide to move forward including direct loans, joint ventures and government incentive programs.
Danny Chen, Chairman and CEO of China Logistics Group, commented "As we continue to look to build our capabilities for the future, the strategy of providing our own warehouse as a center of storage, distribution and transfer at key locations is an important goal for China Logistics Group. By providing proprietary storage, along with transportation and logistics management, we can add substantial value for our clients through a full turnkey solution. We are evaluating this project because it is adjacent to our trucking transportation headquarters, enabling easy and efficient transportation options for domestic distribution as well as to the port. We would also have the ability to use the services of our transportation partner’s network out of this location to enable us to seamlessly move goods from this location to any point in China. We intend to fully explore all aspects of this opportunity as we believe it could serve as a model for us to expand in other locations and provide substantial future growth."
About China Logistics Group, Inc.
China Logistics Group, Inc. (OTCQB: CHLO) is a U.S. company doing business in China through its subsidiary Shandong Jiajia International Freight & Forwarding Co., Ltd. (Shandong Jiajia). Established in 1999; Shandong Jiajia is an international freight forwarder and logistics manager located in China. Shandong Jiajia acts as an agent for international freight and shipping companies. It sells cargo space and arranges land, maritime, and air international transportation for clients seeking primarily to export goods from China. For more information please visit http://www.chinalogisticsinc.com.
Safe Harbor Statement
China Logistics Group, Inc. is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our ability to acquire land use rights and construct, operate and finance a warehouse operation and our expectations regarding client acceptance of our proposed warehouse operations and our future growth, and other risk factors impacting our company, some of which may be beyond our control. We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2011.
Contact:
Dore Perler
U.S. Representative
954-232-5363
dore@pearlgroupadvisors.com
Investorideas.com Disclaimer
Published at Investorideas.com newswire
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. CHLO- one month news publication and email distribution starting February 13, 2013. Disclosure: compensation: three thousand per week plus equivalent in shares      http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Mobile Payment Stock Breaking News; Calpian, Inc. (OTCQB: CLPI) to Present at The Mobile Strategy Summit - New Delhi, March 5, 2013

DALLAS - February 27, 2013 (Investorideas.com mobile payment stocks newswire) Calpian, Inc. (OTCQB:CLPI) announced today that Harold Montgomery, Calpian Chairman and CEO, has been chosen as a featured speaker at the 5th Annual Mobile Strategy Summit to be held at the Taj Mahal hotel in New Delhi, India on March 5. Mr. Montgomery will present Calpian’s Indian mobile payments solution, Money-on-Mobile, and will be joined later that day by Money-on-Mobile Managing Director, Shashank Joshi, to lead a panel discussion about mobile strategies in the developing world.

For more information about The Mobile Strategy Summit, please visit: http://www.fleminggulf.com/conferenceview/The-Mobile-Strategy-Summit/408
About Calpian, Inc.
Calpian, Inc. (OTCQB:CLPI) is a publicly traded company with corporate offices in Dallas, Texas and mobile payments emerging-market operations through its subsidiary in India. Calpian's U.S. business focuses on the 10,000 Independent Sales Organizations (ISOs) that serve approximately 2 million small merchants across all industries in the U.S. who pay an estimated $1 billion in annual residuals. Calpian’s Indian subsidiary offers Money-on-Mobile, a pre-paid mobile payment solution, to over 32.5 million unique Indian phone number customers at more than 118,000 Indian retail locations. Calpian's management team has over 70 years in combined experience in the payments business. Calpian's CEO, Harold Montgomery, is a recognized industry leader who has provided expert testimony to the U.S. Congress and Federal Reserve Bank on payments-related issues and regularly appears in numerous industry publications, such as Transaction World Magazine. Please visit our website at www.calpian.com for more information.
About Money-on-Mobile
Money-On-Mobile is a mobile payment service provider that offers pre-paid and electronic payment instruments to mobile phone subscribers for purchasing goods and/or services. MOM has a strong team of professionals from various backgrounds (Telecom, Finance, Operations, Training, ITES, Technology, Banking, Legal) to achieve the brands’ common objective of “Implementing Mobile Payments System using M-Wallet” in the Indian market. M-wallet solution makes it possible for customers to make secured payments anytime and anywhere. MOM is headquartered in Mumbai. www.money-on-mobile.net.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy, liquidity, and building a larger credit facility. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Contact:
Calpian, Inc.
Cynthia Bailey, 214-758-8600
Chief Marketing Officer
cbailey@calpian.com
or
Company Contact:
Harold Montgomery, 214-758-8600
CEO
haroldmontgomery@calpian.com
or
Investor Relations Contact:
John Liviakis, 415-389-4670
john@Liviakis.com
Published at Investorideas.com newswire
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure : Calpian ( OTC:CLPI) compensates Investorideas.com for news publishing and distribution and company profile : effective December 19th 2012 : five thousand per month and restricted 144 shares. http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Tuesday, February 26, 2013

Mining Stock News: SilverCrest (TSX.V: SVL) (NYSE MKT: SVLC) Continues to Expand Santa Elena Deposit

VANCOUVER, BRITISH COLUMBIA - February 26, 2013 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX.V:SVL) ( NYSE MKT: SVLC) (CW5.F) ("SilverCrest" or the "Company") is pleased to announce results of further delineation drilling at the Santa Elena Mine in Sonora, Mexico. One hundred and eleven holes of a revised planned 114 holes have been completed to re-categorize Indicated and Inferred Resources to Probable Reserves and expand current underground Resources (see Figure - http://media3.marketwire.com/docs/svl226-F1.pdf). This drill program continues to be extremely successful and several of the most recent holes have identified additional bonanza grade (as defined below) intercepts and two new zones (El Cholugo and El Cholugo Dos) that lie below and are sub-parallel to the Main Mineralized Zone currently being mined. All holes included in this program will assist with resource confirmation and reclassification, the results of which will be included in the upcoming Pre-Feasibility Study for the Santa Elena Expansion Project.

J. Scott Drever, President stated; "This delineation drill program has been immensely successful. We have drilled the known portion of the deposit at 35 to 40 metre centres, the Main Mineralized Zone has been extended by approximately 300 metres beyond our current resource boundary and we have identified two new sub-parallel zones, El Cholugo and El Cholugo Dos. We are eagerly awaiting the results of the revised underground resource and reserve estimations that are intended to extend the mine life well beyond the existing 6.5 year life of the current open pit heap leach. Our underground decline has progressed beyond 1,200 metres and a number of muck bays are within 25 metres of the underground portion of the ore deposit which will allow for early development of the deposit."
In this reported series, core holes SE-13-117, SE-13-119 and GT-12-09 have intercepted further Bonanza grades of silver (greater than 1,000 gpt Ag) ranging from 1.0 metre @ 1.50 gpt Au and 1,320 gpt Ag to 1.9 metres @ 2.34 gpt Au and 1,281.9 gpt Ag (see tables below).
Assay values in this series of holes range from 0.3 gpt to 27.2 gpt gold and 54.7 gpt to 1,320.0 gpt silver. Mineralized intervals range from 1.7 metres to 25.8 metres. All mineralized drill intercepts are near true thicknesses. The most significant assay results in this series of holes are shown in the following tables;
Investorideas.com Newswire Investorideas.com Newswire All sample analyses were completed by ALS Chemex in Hermosillo, Mexico and North Vancouver, BC.
Assays for Hole SE-12-60, SE-12-61, and SE-12-75 were pending in a previous news release and are now presented above. Hole GT-12-09 previously reported only the Main Mineralized Zone with the El Cholugo Zone intercept now reported above.
The El Cholugo Zone continues to expand with 5 new drill hole intercepts. The dimensions of this newly discovery zone are now approximately 200 metres long by 100 metres high and open to the west and to depth. A new parallel mineralized zone (EL Cholugo Dos) was intercepted below the El Cholugo discovery in hole SE-13-117 with 10.4 metres @ 0.78 gpt Au and 76.7 gpt Ag; hole SE-13-118 with 4.2 metres @ 0.90 gpt Au and 70.8 gpt Ag, and hole SE-13-119 with 4.5 metres @ 4.83 gpt Au and 72.3 gpt Ag. Dimensions of this new discovery are currently unknown with further drilling anticipated to test this mineralization. Both of these new zones will be easily accessible from the underground development of the adjacent Main Mineralized Zone. A series of holes are being drilled to the west of SE-13-117 to test all three zones at depth.
Several Holes reported previously (Holes SE-12-72, SE-12-73, SE-12-74, and SE-12-111) extended the strong silver and gold mineralization along the Main Mineralized Trend to the east and to depth. These intercepts are up to 200 metres beyond the boundary of current resource estimates. This area beyond previous resource boundaries is now approximately 300 metres long by 200 metres high by 5 to 10 metres thick and open to the east and to depth and will be included in the upcoming revised resource estimates. Further drilling is underway to help delineate this area of potential expansion.
Approximately 39,000 metres of drilling have been completed to date in the program to convert underground resources to reserves and expand total resources. Results for the next series of holes will be released once compilation of results is complete. Three drills are currently on site completing the in-fill program. Further expansion drilling, beyond the in-fill program, will continue in 2013. Revised Santa Elena Resources and Reserves are expected in Q1 2013 with subsequent reporting of the results of Pre-Feasibility Study for the Expansion Plan.
The Qualified Person under National Instrument (NI 43-101) Standards of Disclosure for Mineral Projects for this News Release is N. Eric Fier, CPG, P.Eng, and Chief Operating Officer for SilverCrest Mines Inc., who has reviewed and approved its contents.
SilverCrest Mines Inc. (TSX-V: SVL; NYSE MKT: SVLC) is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest's flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, Mexico. The mine is a high-grade, epithermal gold and silver producer, with an estimated life of mine cash cost of US$8 per ounce of silver equivalent (55:1 Ag:Au). SilverCrest anticipates that the 2,500 tonnes per day facility should recover approximately 4,805,000 ounces of silver and 179,000 ounces of gold over the 6.5 year life of the open pit phase of the Santa Elena Mine. A three year expansion plan is underway to double metals production at the Santa Elena Mine and exploration programs are rapidly advancing the definition of a large polymetallic deposit at the La Joya property in Durango State.
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company's anticipated results and developments in the Company's operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company's ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company's status as a foreign private issuer in the United States; risks related to all of the Company's properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company's forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
The information provided in this news release is not intended to be a comprehensive review of all matters and developments concerning the Company. It should be read in conjunction with all other disclosure documents of the Company. The information contained herein is not a substitute for detailed investigation or analysis. No securities commission or regulatory authority has reviewed the accuracy or adequacy of the information presented.
J. Scott Drever, President
SILVERCREST MINES INC.
Contact:
SilverCrest Mines Inc.
Fred Cooper
(604) 694-1730 ext. 108
Toll Free: 1-866-691-1730
(604) 694-1761 (FAX)
info@silvercrestmines.com
www.silvercrestmines.com
570 Granville Street, Suite 501
Vancouver, British Columbia V6C 3P1
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Monday, February 25, 2013

Stevia Stock Trading Alert; Sunwin Stevia (OTCQB: SUWN) Gains over 11% on News

Point Roberts, WA - February 25, 2013 (Investorideas.com Newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors issues a trading alert and news for agriculture stevia stock, Sunwin Stevia International, Inc. (OTCQB:SUWN). The stock is trading at $0.24, gaining $0.02 (11.63%) as of 2:05PM EST following news earlier today.

The Company reported that it will attend and exhibit at Engredea 2013 to be held at the Anaheim Convention Center in Anaheim, CA, from Friday March 8, 2013 to Sunday, March 10, 2013.
Management of Sunwin Stevia will take this opportunity to showcase its wide range of stevia extracts and products during the three day event at booth 347.
Investorideas.com Newswire Full news: http://www.investorideas.com/CO/SUWN/news/2013/02251.asp
About Sunwin Stevia International, Inc.
Sunwin Stevia International, Inc. engages in the areas of zero calorie, all natural sweeteners (Sunwin Stevia™ Extracts). As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin, please visit http://www.sunwininternational.com
WILD Flavors Gmbh is the worldwide distribution partner and developer of Sunwin Stevia™ sweeteners using Sunwin Stevia™ extracts.
WILD Flavors GmbH , based in Zug, Switzerland, is one of the world's leading privately-owned manufacturers of natural ingredients for the food and beverage industry. WILD Flavors provides specific flavors, colors, and ingredients as well as innovative and great tasting concepts through application expertise and technological advancements. www.wildflavors.com or www.wild.de.
Research more Agriculture and stevia stocks at Investorideas.com ( NASDAQ:SANW) (NYSE:INGR), (LSE:PURE.L), (OTC:STVF)
http://www.investorideas.com/MSS/Arg_Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
More Sunwin info at Investorideas.com http://www.investorideas.com/CO/SUWN/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com is compensated by China Direct on behalf of SUWN, 40,000 144 shares for news publication, dissemination and profile on Invesotrideas.com , its affiliate news and email sites http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Stevia Stock Investor Alert; Sunwin Stevia International (OTCQB: SUWN) to Attend and Exhibit Its All Natural Sunwin Stevia Products at Engredea 2013

QUFU, China - February 25, 2013 (Investorideas.com Newswire) Sunwin Stevia International, Inc. "Sunwin Stevia" (OTCQB: SUWN) one of the top global providers of high quality stevia extracts including Rebaudioside A 98, announced today that it will attend and exhibit at Engredea 2013 to be held at the Anaheim Convention Center in Anaheim, CA, from Friday March 8, 2013 to Sunday, March 10, 2013.

Engredea brings together the community of leading suppliers and manufacturers to source new ingredients, packaging, technologies, equipment, and services in the global nutrition industry. Engredea, co-located with Natural Products Expo West, is the only tradeshow that brings together the full food chain of supply to shelf. Engredea cultivates innovation for tomorrow's best-selling products across food/ beverage, dietary supplement and nutricosmetic categories by offering hundreds of exhibits, formulation demos, networking events and education opportunities for the industry.
Management of Sunwin Stevia will take this opportunity to showcase its wide range of stevia extracts and products during the three day event at booth 347.
About Sunwin Stevia International, Inc.
Sunwin Stevia International, Inc. engages in the areas of zero calorie, all natural sweeteners (Sunwin Stevia™ Extracts). As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin, please visit http://www.sunwininternational.com
Safe Harbor Statement
Sunwin Stevia International, Inc. is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our ability to return our revenues to historical levels, our dependence on continued market acceptance of our products, competition, our ability to control our raw material costs, risks associated with operating in China, and other risk factors impacting our company, some of which may be beyond our control. We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2012.
Contact Sunwin Stevia:
Dore Perler
U.S. Representative
954-232-5363
ir@sunwininternational.com
Published at Investorideas.com Newswire
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com is compensated by China Direct on behalf of SUWN, averaging four thousand per week for news publication, dissemination and profile on Investorideas.com, its affiliate news and email sites http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Stevia Stock Investor Alert; Sunwin Stevia International (OTCQB: SUWN) to Attend and Exhibit Its All Natural Sunwin Stevia Products at Engredea 2013

QUFU, China - February 25, 2013 (Investorideas.com Newswire) Sunwin Stevia International, Inc. "Sunwin Stevia" (OTCQB: SUWN) one of the top global providers of high quality stevia extracts including Rebaudioside A 98, announced today that it will attend and exhibit at Engredea 2013 to be held at the Anaheim Convention Center in Anaheim, CA, from Friday March 8, 2013 to Sunday, March 10, 2013.

Engredea brings together the community of leading suppliers and manufacturers to source new ingredients, packaging, technologies, equipment, and services in the global nutrition industry. Engredea, co-located with Natural Products Expo West, is the only tradeshow that brings together the full food chain of supply to shelf. Engredea cultivates innovation for tomorrow's best-selling products across food/ beverage, dietary supplement and nutricosmetic categories by offering hundreds of exhibits, formulation demos, networking events and education opportunities for the industry.
Management of Sunwin Stevia will take this opportunity to showcase its wide range of stevia extracts and products during the three day event at booth 347.
About Sunwin Stevia International, Inc.
Sunwin Stevia International, Inc. engages in the areas of zero calorie, all natural sweeteners (Sunwin Stevia™ Extracts). As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin, please visit http://www.sunwininternational.com
Safe Harbor Statement
Sunwin Stevia International, Inc. is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our ability to return our revenues to historical levels, our dependence on continued market acceptance of our products, competition, our ability to control our raw material costs, risks associated with operating in China, and other risk factors impacting our company, some of which may be beyond our control. We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2012.
Contact Sunwin Stevia:
Dore Perler
U.S. Representative
954-232-5363
ir@sunwininternational.com
Published at Investorideas.com Newswire
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com is compensated by China Direct on behalf of SUWN, averaging four thousand per week for news publication, dissemination and profile on Investorideas.com, its affiliate news and email sites http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894